<DOC>
	<DOCNO>NCT01063881</DOCNO>
	<brief_summary>The purpose study measure efficacy flexible dose dapoxetine set similar routine clinical practice .</brief_summary>
	<brief_title>The Asia-Pacific Flexible Dose Study Dapoxetine Patient Satisfaction Premature Ejaculation Therapy</brief_title>
	<detailed_description>This prospective , interventional study evaluate efficacy safety flexible dose dapoxetine Premature Ejaculation ( PE ) Therapy . The total study duration 16 week , compose 2-week pretreatment phase 12-week open-label treatment phase , follow telephone contact two week Week 12 follow-up adverse event . At Visit 1 ( Screening ) standardize assessment tool patient questionnaire use determine patient erectile dysfunction/premature ejaculation eligible participate study . Once enrolled patient partner expect attempt sexual intercourse minimum 2 time ( least 24 hour apart ) complete Baseline Event Log . Starting Visit 2 ( Baseline ) , patient ( partner ) complete Premature Ejaculation Profile ( PEP ) begin every treatment visit duration study . Patients start study drug instruct take 1 tablet dapoxetine 30 mg , need , 1 3 hour prior sexual activity . The need adjustment dose dapoxetine , well assess occurrence adverse event concomitant therapy use assess approximately every 4 week . Patients complete Treatment Event Logs dose throughout open-label treatment phase . Patients dose increased 60 mg , schedule telephone consultation 1 week determine dose change tolerate . At Visit 5 ( Final Visit/Week 12/Early Termination ) , patient partner complete several standardize assessment questionnaire final visit procedure perform schedule telephone follow contact evaluate adverse event . The start dose dapoxetine 30 mg ( one 30-mg tablet ) , take approximately 1 3 hour prior sexual activity . The dose may increase 4 week 60 mg take . The maximum recommend dosing frequency every 24 hour .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<mesh_term>Sexual Dysfunction , Physiological</mesh_term>
	<criteria>Participants must heterosexual male stable monogamous , sexual relationship female partner least 6 month must score =11 Premature Ejaculation Diagnostic Tool ( PEDT ) Must selfestimated intravaginal ejaculatory latency time ( IELT ) = 2 minute Must International Index Erectile Dysfunction ( IIEF ) score total &gt; = 21 6 question IIEF use assess absence moderate severe erectile dysfunction ( ED ) Premature ejaculation exclusively due direct effect substance ( e.g. , withdrawal opioids ) Must good general health clinically significant abnormality determine medical history , physical examination , clinical lab result Must blood pressure =180 mmHg systolic =100 mmHg diastolic screen baseline visit Patient 's partner must pregnant screen pregnancy might affect sexual activity Participants partner must agree attempt sexual intercourse least 2 time ( minimum 24 hour event ) 2week baseline period least 4 time per month remainder study . History current major psychiatric disorder mood disorder , anxiety disorder , schizophrenia , mania , suicidal ideation , psychotic disorder History alcohol abuse dependence , nonalcohol psychoactive substance use disorder ( except caffeine nicotine/tobacco ) Suspected history illicit recreational drug use Known history moderate severe renal impairment</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Sexual Dysfunction , physiological</keyword>
	<keyword>R096769</keyword>
	<keyword>Dapoxetine</keyword>
	<keyword>Phase 3b</keyword>
	<keyword>Premature Ejaculation</keyword>
</DOC>